<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03446937</url>
  </required_header>
  <id_info>
    <org_study_id>AhmaduBUTH</org_study_id>
    <nct_id>NCT03446937</nct_id>
  </id_info>
  <brief_title>Effect of Antenatal Corticosteroids on Neonatal Morbidity.</brief_title>
  <official_title>Effect of Antenatal Corticosteroids on Neonatal Morbidity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ahmadu Bello University Teaching Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ahmadu Bello University Teaching Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It will be a randomized controlled trial. There will be two study groups. Study group 1 will
      be given dexamethasone while study group 2 will be given betamethasone. The control group
      will be given placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be a double blind randomised controlled trial. There will be two study groups
      and one control group.

      The first study group will be the pregnant women at risk of late preterm birth that will
      receive antenatal corticosteroids in the form of intramuscular dexamethasone sodium
      phosphate.

      The second study group will be the pregnant women at risk of late preterm birth that will
      receive antenatal corticosteroids in the form of intramuscular betamethasone sodium
      phosphate.

      The control group will be pregnant women at risk of late preterm birth that will be given
      intramuscular water for injection.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2017</start_date>
  <completion_date type="Anticipated">December 14, 2018</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised controlled trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
    <masking_description>double blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Neonatal Respiratory distress syndrome</measure>
    <time_frame>Within the first 72 hours of life</time_frame>
    <description>Tachypnoea with grunting, recession, or nasal flaring with diffuse reticulogranular infiltrate on X-ray and oxygen requirement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transient tachypnoea of the newborn:</measure>
    <time_frame>Within the first 72 hours after delivery/birth</time_frame>
    <description>As determined by local treatment protocols at Ahmadu Bello University Teaching Hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Admission into neonatal intensive care unit.</measure>
    <time_frame>Within the first 72 hours after delivery/birth</time_frame>
    <description>As determined by local treatment protocols at Ahmadu Bello University Teaching Hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>2. Admission into neonatal intensive care unit. Apnoea.</measure>
    <time_frame>Within the first 72 hours after delivery/birth</time_frame>
    <description>As determined by local treatment protocols at Ahmadu Bello University Teaching Hospital</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Neonatal Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Dexamethasone sodium phosphate injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Drug: Dexamethasone sodium phosphate injection Two doses Intramuscular Dexamethasone sodium phosphate 12mg given12 hours apart. (produced by Taizhou Overseas International Ltd. 126-128 Qingnian Road Jiaojiang, Taizhou, Zhejiang, China)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Betamethasone sodium phosphate injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Drug: Betamethasone sodium phosphate injection Two doses of intramuscular betamethasone sodium phosphate 12mg given 12 hours apart. (obtained from Twinbrook pkwy, Rockville, MD Singapore. CAT No 1068004, Lot: R004e0)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water for injection</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Intervention. Drug: Water for injection. Two doses of intramuscular water for injection given 12 hours apart.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Sodium Phosphate Injection</intervention_name>
    <description>Dexamethasone sodium phosphate injection 12 mg X doses to be given 12 hours apart</description>
    <arm_group_label>Dexamethasone sodium phosphate injection</arm_group_label>
    <other_name>Pemadex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Betamethasone Sodium Phosphate Injection (Medication)</intervention_name>
    <description>betamethasone sodium phosphate injection12mg X 2 doses given 12 hours apart</description>
    <arm_group_label>Betamethasone sodium phosphate injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Water for injection</intervention_name>
    <description>Two doses of intramuscular injection of water for injection given 12 hours apart</description>
    <arm_group_label>Water for injection</arm_group_label>
    <other_name>Juhel water for injection</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation and a probability of
             delivery in the late preterm period irrespective of diagnosis who give consent.

          -  Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation scheduled for
             elective/emergency delivery in the late preterm period irrespective of indication and
             route of delivery who give consent.

        Exclusion Criteria:

          -  Evidence of Chrioamnionitis.

          -  Evidence of foetal distress.

          -  History of use of antenatal corticosteroids in index pregnancy.

          -  Women who do not give consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anisah Yahya, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ahmadu Bello University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anisah Yahya, MBBS</last_name>
    <phone>+2348035925175</phone>
    <email>anisahy@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hajaratu S Umar, MBBS</last_name>
    <phone>08034505318</phone>
    <email>hajaratuumar@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ahmadu Bello University Teaching Hospital Shika-Zaria</name>
      <address>
        <city>Zaria</city>
        <state>Kaduna</state>
        <zip>PMB 06</zip>
        <country>Nigeria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anisah Yahya, MBBS</last_name>
      <phone>08035925175</phone>
      <email>anisahy@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Hajaratu Umar, MBBS</last_name>
      <phone>08034505318</phone>
      <email>hajaratuumar@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ahmadu Bello University Teaching Hospital</investigator_affiliation>
    <investigator_full_name>Anisah Yahya</investigator_full_name>
    <investigator_title>Lecturer I/Fellow</investigator_title>
  </responsible_party>
  <keyword>Antenal corticosteroids</keyword>
  <keyword>Late preterm delivery</keyword>
  <keyword>Neonatal morbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Hyaline Membrane Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Betamethasone benzoate</mesh_term>
    <mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Betamethasone</mesh_term>
    <mesh_term>Betamethasone Valerate</mesh_term>
    <mesh_term>Betamethasone sodium phosphate</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

